Novavax stock rises more than 20% after the study of the COVID-19 vaccine shows almost 90% effectiveness in the UK, but less against the new South African variant
As the EU fights the shortage of AstraZeneca, the United Kingdom continues to manufacture the new vaccine COVID
Dr. Fauci says that Covid vaccines can be easily adapted to new variants, drug manufacturers working on reinforcements